Prof Ajay Shah appointment

Following a global search, King’s College London has appointed Prof Ajay Shah has as Executive Dean of the Faculty of Life Sciences & Medicine (FoLSM) from 1 September 2021. 

Prof Shah [pictured right] has been Interim Dean of the Faculty since January 2021, and has worked at King’s College London for over 20 years. Prof Shah comes with a great breadth of knowledge of the Faculty, the university and trusts that make up King’s Health Partners.  

He has held positions as Professor of Cardiology and Head of the School of Cardiovascular Medicine and Sciences, Director of the King's British Heart Foundation Centre of Research Excellence, Director of King’s Health Partners Cardiovascular and is now an Honorary Consultant Cardiologist at King's College Hospital NHS Foundation Trust. 

Prof Shah has an extensive research portfolio, having published approximately 400 peer-reviewed papers. He is a Fellow of the UK Academy of Medical Sciences, the International Society for Heart Research, the European Society of Cardiology and the American Heart Association. Prof Shah is also Consulting Editor for Cardiovascular Research, and sits on the Editorial Boards of Circulation and the European Heart Journal. 

On this appointment, Prof Richard Trembath, Executive Director, King’s Health Partners and Senior Vice President (Health & Life Sciences), King’s College London said:  

I am pleased to congratulate Ajay on his appointment. As Executive Dean, Ajay will lead the Faculty in delivering an ambitious strategy that builds on its excellence in education, training and research and boost its local and global impact even further at this critical time as the world recovers from the COVID-19 pandemic.

Prof Shah’s main research interests are in the pathophysiology of heart failure and during the pandemic, he and his team have led crucial research on how a patient’s ethnic background affects their risk of severe disease and death.   

Learn how King’s Health Partners Cardiovascular aims to transform service delivery and generate research advances to revolutionise cardiovascular prevention and care.